Multiple Sclerosis Center at UCSF

San Francisco, California 94158

0 studies enrolling now · 4 studies all time

What they study most

Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis — Completed
• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
• Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS — Completed
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis — Completed